Diazepine containing dual action inhibitors

Details Diazepine containing dual action inhibitors Diazepine containing dual action inhibitors

1996-03-01

1997-06-03

Bond, Robert T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

540492, 540500, 544232, 544238, 544239, 514221, 514227, 514248, A61K 3155, C07D24302

Patent

active

056355041

ABSTRACT:
Compounds of the formula ##STR1## wherein: ##STR2## A is are dual inhibitors of NEP and ACE. Compounds wherein A is ##STR3## are selective ACE inhibitors.

REFERENCES:
patent: 3856798 (1974-12-01), Meyer et al.
patent: 4105776 (1978-08-01), Ondetti et al.
patent: 4186200 (1980-01-01), Kubo et al.
patent: 4192945 (1980-03-01), Ondetti
patent: 4225495 (1980-09-01), Ondetti
patent: 4337201 (1982-06-01), Petrillo, Jr.
patent: 4339600 (1982-07-01), Ondetti et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4409146 (1983-10-01), Thorsett et al.
patent: 4410520 (1983-10-01), Watthey
patent: 4415496 (1983-11-01), Harris et al.
patent: 4432971 (1984-02-01), Karanewsky et al.
patent: 4432972 (1984-02-01), Karanewsky et al.
patent: 4460579 (1984-07-01), Karanewsky
patent: 4465679 (1984-08-01), Huang et al.
patent: 4470988 (1984-09-01), Watthey
patent: 4473575 (1984-09-01), Watthey
patent: 4477464 (1984-10-01), Slade et al.
patent: 4512924 (1985-04-01), Attwood et al.
patent: 4537885 (1985-08-01), Watthey
patent: 4539150 (1985-09-01), Katakami et al.
patent: 4548932 (1985-10-01), Sugihara et al.
patent: 4575503 (1986-03-01), Watthey
patent: 4584294 (1986-04-01), Ruyle
patent: 4587050 (1986-05-01), Harris et al.
patent: 4587238 (1986-05-01), Harris et al.
patent: 4594341 (1986-06-01), Cheung et al.
patent: 4617301 (1986-10-01), Patchett et al.
patent: 4629787 (1986-12-01), Harris et al.
patent: 4680392 (1987-07-01), Harris et al.
patent: 4699905 (1987-10-01), Yanagisawa et al.
patent: 4711884 (1987-12-01), Karanewsky
patent: 4722810 (1988-02-01), Delaney et al.
patent: 4734410 (1988-03-01), Yanagisawa et al.
patent: 4749688 (1988-06-01), Haslanger et al.
patent: 4801609 (1989-01-01), Haslanger et al.
patent: 4824832 (1989-04-01), Flynn et al.
patent: 4873235 (1989-10-01), Parsons et al.
patent: 4879309 (1989-11-01), Doll et al.
patent: 4963539 (1990-10-01), Delaney
patent: 4973585 (1990-11-01), Flynn et al.
patent: 5061710 (1991-10-01), Haslanger et al.
patent: 5075302 (1991-12-01), Neustadt
patent: 5098934 (1992-03-01), Vevert et al.
patent: 5190974 (1993-03-01), Clemence et al.
patent: 5208236 (1993-05-01), Neustadt
patent: 5223516 (1993-06-01), Delaney et al.
patent: 5225401 (1993-07-01), Seymour
patent: 5232920 (1993-08-01), Neustadt
patent: 5238924 (1993-08-01), Smith
patent: 5262436 (1993-11-01), Haslanger et al.
patent: 5362727 (1994-11-01), Robl
patent: 5366973 (1994-11-01), Flynn et al.
patent: 5504080 (1996-04-01), Karanewsky
patent: 5508272 (1996-04-01), Robl
patent: 5525723 (1996-06-01), Robl
patent: 5552397 (1996-09-01), Karanewsky
Adams et al., Synthetic Communications, vol. 18, 2225-2231 (1988).
Attwood et al., FEBS Letters, vol. 165, pp. 201-206 (1984).
Attwood et al., J. Chem. Soc. Perkin Trans I (1986) pp. 1011-1019.
Bolos et al., J. Org. Chem., 57, 3535-3539 (1992).
Bolos et al., Tetrahedron, vol. 48, pp. 9567-9576 (1992).
Boyer, T. D. "Cirrhosis of the Liver and Its Major Sequelae" in: Wyngaarden, J. B. et al., Cecil Textbook of Medicine, vol. 1 (Saunders Co., 1992) pp. 786-789.
Chackalamannil et al., Bioorganic & Medicinal Chemistry Letters, vol. 2, pp. 1003-1006 (1992).
Das et al., Bioorganic & Medicial Chemistry Letters, vol. 4, pp. 2193-2198 (1994).
Delaney et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 1783-1788 (1994).
Dussaule et al., Jour. of Clinical Endocrinology and Metabolism, vol. 72, pp. 653-659 (1991).
Fernandez-Cruz, The Lancet, Dec. 21/28, pp. 1439-1440 (1985).
Flynn et al., J. Med. Chem., 36, pp. 2420-2423 (1993).
Flynn, Tetrahedron Letters, vol. 31, pp. 815-818 (1990).
Fobian et al., 206th Meeting of the Amer. Chem. Society, Aug. 1993 Abstr. ORG 297.
Fyhrquist et al., The Lancet, Dec. 21/28, p. 1439 (1985).
Hanau et al., 206th Meeting of the Amer. Chem. Society, Aug. 1993 Abstr. ORG 298.
Itoh et al., Chem. Pharm. Bull., vol. 34, pp. 1128-1147 and 2078-2089 (1986).
Laffi et al., Gastroenterology, vol. 96, pp. 167-177 (1989).
Moeller et al., Tetrahedron Letters, vol. 33, pp. 6041-6044 (1992).
Naming and Indexing of Chemical Substances for Chemical Abstracts, 1987 Index Guide, Section 203.
Natoff et al., Drugs Of the Future, vol. 12, pp. 475-483 (1987).
Parsons et al., Biochem and Biophysical Research Comm. 117, pp. 108-113 (1983).
Robl et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 1789-1800 and 2055-2060 (1994).
Robl et al., J. Am. Chem. Soc., 116, pp. 2348-2355 (1994).
Robl, Tetrahedron Letters, vol. 35, pp. 393-396 and 1393-1396 (1994).
Slade et al., J. Med. Chem., 28, pp. 1517-1521 (1985).
Smith et al., Biochemistry, vol. 14, pp. 766-771 (1975).
Thorsett et al., J. Med. Chem., 29, pp. 251-260 (1986).
Thorsett, Actual Chim. Ther., vol. 13, pp. 257-268 (1986).
Watthey et al., J. Med. Chem., 28, pp. 1511-1516 (1985).
Yanagisawa et al., J. Med. Chem., 30, pp. 1984-1991 (1987).
Yanagisawa et al., J. Med. Chem., 31, pp. 422-428 (1988).

Affiliated with

Also associated with

Rating

Diazepine containing dual action inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diazepine containing dual action inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazepine containing dual action inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-391852